Similar companies
Analyzing X Mentions, how is Astrazeneca performing compared to its industry peers?
Astrazeneca underperforms its industry peers when it comes to X Mentions, ranking in the 5th percentile.
Why should an investor track X mentions?
Investors should track mentions of Astrazeneca on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.
Sign up and get more insights on Astrazeneca.
Sentiment on X
The sentiment score for Astrazeneca on X is 58 (out of 100). This is considered neutral. Sentiment today is up compared to the 30 moving average.
Top Mentions
$AZN scrapped a clinical trial collaboration over Asher Bio's CD8-guided IL-2, then started its own study...Oct 24 - 1 retweets |
Hopefully $AZN moved on ??Oct 22 - 0 retweets |
$AZN: AstraZeneca and Amgen (AMGN) receive approval of Tezspire in EU https://t.co/KIoANZ56IZOct 22 - 0 retweets |
@cngarabedian @BrianSkorney @SamFazeli8 @LifeSciVC @JMaraganore @daphnezohar @MatteisPaul @bradloncar...Oct 24 - 0 retweets |
$AZN A cautionary tale for clinical trial collaborators https://t.co/NlFptBtEgOOct 26 - 0 retweets |
